Data-driven risk identification in phase III clinical trials using central statistical monitoring
Crossref DOI link: https://doi.org/10.1007/s10147-015-0877-5
Published Online: 2015-08-02
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Timmermans, Catherine
Venet, David
Burzykowski, Tomasz
Text and Data Mining valid from 2015-08-02